Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
gpASIT+ in hay fever
NCT02156791Phase 2Completed
- Sponsor
- TOOLS Life Science
- Start
- Aug 2013
- Primary completion
- Dec 2013
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of gpASIT+ in Seasonal Allergic Rhinoconjunctivitis (SAR), sponsored by TOOLS Life Science. Started Aug 2013; status: completed.
02
Drugs
gpASIT+
03
Conditions
Seasonal Allergic Rhinoconjunctivitis (SAR)
Beyond the preview
Go deeper on NCT02156791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02156791.